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Abstract: Background: We aimed to measure and correlate inner retinal layer (IRL) thickness and
macular sensitivity by optical coherence tomography (OCT) and by microperimetry, respectively,
in type 1 diabetes mellitus patients (DM1) without diabetic retinopathy (DR). Methods: Fifty-one
DM1 patients and 81 age-matched healthy subjects underwent measurement of the axial length (AL),
retinal thickness in the macular ETDRS areas by swept source (SS)-OCT and macular sensitivity
by microperimeter. Results: The total retinal and IRL thicknesses were thicker in the DM1 group
(p < 0.05) in practically all ETDRS areas, and they had a generalized decrease in sensitivity (p < 0.05) in
9 areas between both groups. There was a significant negative correlation between retinal sensitivity
and age in all areas and in visual acuity (VA) in 5 out of the 9 areas for DM1 patients. Only a
mild negative correlation was observed between retinal sensitivity in the 5◦ nasal inner (5NI) area
and in IRL thickness in the temporal inner (TI) area (−0.309 with p = 0.029) in the DM1 group.
Conclusion: Aging and disease evolution in DM1 patients without DR signs generate a decrease in
retinal sensitivity. There was a direct relationship between retinal sensitivity and macular thickness
in the DM1 group.
Keywords: diabetic retinopathy; total retinal thickness; inner retinal layer thickness; ophthalmology;
macular sensitivity; microperimetry; swept source optical coherence tomography (SS-OCT);
type 1 diabetes mellitus
1. Introduction
Although diabetic retinopathy (DR) is regarded mainly as a microvascular disorder [1],
there is evidence that supports the appearance of functional changes in early stages [2,3].
It suggests that prior to the appearance of DR, there is neurodegeneration that causes
functional [4,5] and structural abnormalities [6,7], such as a decrease in retinal sensitivity
detectable by microperimetry [8–10] or changes in macular thickness seen on optical
coherence tomography (OCT) [11,12].
In diabetes, there is evidence of increased retinal cell apoptosis [13], which begins
affecting the ganglion cell (GC) bodies with shrinkage of dendritic arbors and their conse-
quent axonal involvement [14]. Neuronal changes can be detected measuring the different
inner retinal layers (IRL), such as the retinal nerve fiber layer (RNFL), the GC layer (GCL)
and the inner plexiform layer (IPL), known as the ganglion cell complex (GCC), in addition
to the total retinal thickness by OCT. Previous studies have demonstrated changes in the
total retinal thickness and IRL thickness in diabetic patients without DR [11,15–18].
Microperimetry shows decreased macular sensitivity despite high visual acuity (VA)
in diabetic patients without DR signs [8–10], suggesting that microperimetry may give
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additional information reflecting functional impairment in diabetic patients before vascular
manifestations occur.
Many studies indicate early neurodegeneration in diabetes in terms of functional
and morphological impairments, but only a few of them have correlated OCT changes
with retinal sensitivity results [19,20]. Diabetic subjects with no or minimal vascular signs
have been evaluated by spectral domain (SD)-OCT and by microperimetry, but only mean
foveal sensitivity and foveal thickness measurements have been analyzed. Moreover, to
our knowledge, the correlation between the IRL and retinal sensitivity of the macula was
only investigated by Montesano et al. [8].
The purpose of this study was to measure the total retinal thickness and the different
IRL thicknesses by swept source (SS)-OCT and macular sensitivity by microperimetry in
type 1 diabetes mellitus (DM1) patients without diabetic retinopathy (DR) and to compare
the results with those of healthy subjects. In addition, we studied the correlation of the
structural and functional data obtained from the ETDRS macular grid.
2. Materials and Methods
This study was developed following the principles established in the Declaration of
Helsinki and after the approval of the Ethics Committee for Clinical Research of Aragon
(CEICA 18/2017), approved on 17 October 2017. Written informed consent was explained
and signed by each participant before carrying out any type of exploration, giving them
the freedom to leave the study at any time.
It is a prospective observational study on macular retinal thickness and sensitivity
in 51 DM1 patients without DR signs with good glycemic control and in 81 age-matched
healthy subjects from October 2018–October 2019. All the patients were evaluated at
the Ophthalmology Department of the Lozano Blesa University Hospital by the same
investigator.
The DM1 patients participating in the study had at least 9 years of disease evolution
with no signs of DR identified by biomicroscopy, retinography or structural OCT. They
were well controlled by the endocrinology unit. Blood samples were analyzed every six
months. Glycosylated hemoglobin (HbA1c), lipid values and arterial blood pressure were
maintained under extreme control.
The inclusion criteria were a VA over 20/25 on the Snellen chart to avoid difficulties
in performing ophthalmic tests, refractive errors between +5.00 to −5.00 spherical diopters
and less than 3 diopters of astigmatism, a normal anterior segment examination with slit-
lamp biomicroscopy, intraocular pressure (IOP) less than 20 mmHg measured by Goldman
tonometry and no fundoscopy anomalies observed by ophthalmoscopy, retinography or
structural OCT. A detailed familial, systemic and ophthalmological medical history was
obtained from each patient.
The exclusion criteria were the presence of any sign or manifestation of DR, glau-
coma, optic nerve pathology, ocular inflammation or previous ocular surgery or procedure
including laser therapy, ocular traumatism, anterior segment pathology or media opacifica-
tion. Patients with other systemic pathology or neurodegenerative disease (Alzheimer’s,
Parkinson’s, multiple sclerosis) were also excluded.
VA was measured by the Snellen chart and by the ETDRS 100% contrast test at four
meters in LogMAR scale. The axial length (AL) was measured with the optical biometry
IOLMaster® 500 (Carl Zeiss Meditec, Oberkochen, Germany).
Each participant was imaged by Deep Range Imaging (DRI)-Triton SS-OCT (Topcon
Corporation, Tokyo, Japan) obtaining a macular 6.0 × 6.0 mm three-dimensional scan;
automatic segmentation of each retinal layer was made with IMAGEnet 6 Version software
1.22.1.14101© 2014 Topcon Corporation (Figure 1) to evaluate the structural function of the
retina in 3D [21].
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Figure 1. Segmentation of the different retinal layers as well as the choroid with the DRI Triton swept source optical
coherence tomography (SS-OCT). The provided lines are as follows: ILM, inner limiting membrane line; RNFL, retinal
nerve fiber layer line; IPL, inner plexiform layer line, IS/OS, inner/outer segments line; RPE, retinal pigment epithelium
line; and choroid line.
The DRI Triton SS-OCT in its 3D macula protocol was used to obtain tomographic macular
images and the image quality scale, which ranges from 0 to 100, must be over 60 [22].
The 3D macula protocol measures in the 9 ETDRS areas [23], providing a circular
macular map analysis divided in three concentric circles with diameters of 1, 3 (internal)
and 6 (external) mm. The acquired values were the central or subfoveal area (1 mm, C),
3-mm parafoveal ring with four areas, temporal internal (TI), superior internal (SI), nasal
internal (NI) and inferior internal (II) areas, and four other areas belonging to the 6-mm
perifoveal ring including the temporal external (TE), superior external (SE), nasal external
(NE) and inferior external (IE) areas to study each macular layer thickness (Figure 2). To
evaluate the different layers, the DRI Triton SS-OCT software uses the refringent properties
of each retinal layer.
In our study, we included 3 retinal protocols: the total retinal thickness from the ILM
line to the BM line, called “retina” by the device; the “GCL+” formed by the GCL and
the inner plexiform layer (IPL) (GCL-IPL complex) from the RNFL upper line to the IPL
bottom line; and the “GCL++” or GCC, referring to the sum of the RNFL, GCL and IPL
from the ILM line to the IPL line.
To evaluate the macular sensitivity and functional integrity we used Macular Integrity
Assessment (MAIA, Macular Integrity Assessment system; Topcon Corporation, Tokyo,
Japan) microperimeter in each participant in scotopic conditions and without pupillary
dilation. The MAIA is designed to identify any decrease sensitivity compared to the normal
sensitivity for the patient’s age and to differentiate pathological changes associated with
retinal diseases. This instrument automatically calculates a macular integrity estimation
and an analysis for the residual MS threshold values in dB, classifying macular integrity as
normal (loss of sensitivity less than 40%), suspicious (loss of sensitivity from 40% to 60%)
and out of normal limits (sensitivity losses greater than 60%) [24]. The MAIA software
version was 1.6.3.
During the first 10 s of testing, the instrument calculates the location of the “preferred
retinal locus” (PRL), which serves as an alignment reference, locating the foveola when the
patient looks at the fixation point without stimuli yet projected (PRL-High). Then, a second
estimate of this location is taken at the end of the test, which is the reference point for the
other points (PRL-Low). Both estimated data are graphically represented on the screen; the
MAIA classifies the fixing stability based on the locatio of PRL-Low as follows: stable,
more than two-t irds of the attachment points are center d within th PRL-Low circle;
relatively unstable, more than one-third of the attachment points are centered outside the
Diagnostics 2021, 11, 136 4 of 12
PRL-Low circle; and unstable, less than one-third of the attachment points are centered
within the PRL-Low circle.
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Figure 2. ( ) ET RS grid of a right eye divided into nine areas provided by the Deep Range Imaging
(DRI) Triton SS-OCT. Four areas for the 6-mm perifoveal ring: nasal external (NE), temporal external
(TE), superior external (SE) and inferior external (IE) areas; four areas for the 3 mm parafoveal ring:
nasal internal (NI), temporal internal (TI), superior internal (SI) and inferior internal (II) areas; and
the 1-mm central area. (B) The 37 sensitivity points provided by the Macular Integrity Assessment
(MAIA) microperimeter and its location: one in the center (yellow), 12 in the 1◦ radius (red), 12 in
the 3◦ radius (blue) and 12 in the 5◦ radius (green). One degree is equivalent to a radius of 0.3 mm;
3◦ to a radius of 0.9 mm; and 5◦ to a circle with a 1.5-mm radius. The center point and the 1◦
sensitivity points (0.6-mm diameters) correspond to the ETDRS 1-mm diameter center ring, and
the localized sensitivity points at 3 and 5◦ (diameters of 1.8 and 3 mm, respectively) to the 3-mm
diameter parafoveal ring of the ETDRS grid.
The MAIA sensitivity points were directly correlated to the same areas of the ETDRS
grid provided by DRI-Triton SS-OCT. The MAIA provides 37 sensitivity points including
one in the center, 12 in the 1◦ radius (corresponding to a radius of 0.3 mm), 12 in the
3◦ radius (corresponding to a circle with a 0.9-mm radius) and 12 in the 5◦ radius that
represents a circle with a radius of 1.5 mm. Figure 2 represents the location of the different
points and the ETDRS area in an emmetropic eye.
Thus, the mean of the retinal sensitivity thresholds calculated by the MAIA for the
central and the inner rings were arranged in the central 1-mm ETDRS ring (13 sensitivity
points) and the 3 and 5◦ radius MAIA thresholds corresponded to the SI, NI, II and TI areas
of the 3-mm parafoveal ETDRS ring (mean of 6 sensitivity points per area).
With the MAIA, we evaluated the following data: fixation loss, retinal sensitivity,
macular integrity index, mean total threshold, fixation stability (p1 and p2, percentage of
fixation points with respect to the total within circles with 1◦ and 2◦ radii, respectively,
classified as stable (p1 > 75%), relatively unstable (p1 < 75% and p2 > 75%) or unstable
(p2 < 75%)), bivariate contour ellipse area (BCEA) where the fixation points are contained,
BCEA63 (minor ellipse) and BCEA95 (major ellipse).
All the eyes included in the study had foveal fixation that was checked manually.
Fundoscopic images were extracted and subsequently imported into SS-OCT for analysis
and comparison.
The studied variables were recorded in an Excel database (Microsoft® Office Excel 2011,
Microsoft Corporation). Statistical analysis was performed with the Statistical Package for
the Social Sciences (SPSS 24.0 Inc., IBM Corporation, Armonk, NY, USA).
First, a descriptive statistical analysis of the sample was carried out according to the
demographic variables and clinical characteristics, and the mean and standard deviation of
the continuous quantitative descriptive variables were calculated, while for the qualitative
variables, the absolute frequencies and the corresponding percentages were obtained.
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The distribution of normality of all the variables was also assessed with the Kolmogorov–
Smirnov test. As they did not conform to normality, the non-parametric Mann–Whitney U
test was used for the two independent samples (DM1 group and control group) and Bon-
ferroni correction for multiple comparison was applied considering statistical significant
differences with a value of p < 0.05.
Finally, with the Spearman correlation test, we correlated the anatomical and func-
tional data of the DM1 patients.
3. Results
A total of 132 eyes were analyzed, of which 51 belonged to 51 DM1 patients (46.2%
women and 53.8% men) with an average disease evolution of 25.88 ± 8.42 years and
without DR signs, while 81 eyes corresponded to 81 healthy subjects (54% women and 46%
men) without statistically significant differences between the gender (p = 0.371). The eye of
each participant studied was randomly chosen.
The mean age in healthy controls was 42.41 ± 13.24 years (25 to 68) and the mean
age in DM1 patients was 41.52 ± 13.21 years (24 to 68), without differences between
groups (p = 0.361).
There were no differences (p > 0.05) between groups in mean spherical equivalent
(SE), axial length (AL), IOP or LogMAR VA (Table 1).
Table 1. Mean, standard deviation (SD) and statistical significance (p-value) of visual acuity (VA) in
the LogMAR scale, spherical equivalent (SE) in diopters (D), axial length (AL) in mm and intraocular
pressure (IOP) in mmHg between the control and type 1 diabetes mellitus (DM1) group. No statistical
differences were found between groups (p > 0.05).
Control Group DM1 Group p
Mean SD Mean SD
VA (LogMAR) −0.113 0.07 −0.130 0.01 0.910
SE 0.25 1.85 0.21 2.08 0.369
AL (mm) 23.61 2.14 23.37 1.16 0.297
IOP (mmHg) 16.85 2.47 16.59 3.00 0.150
3.1. Comparative Analysis of the Retinal Thickness
We found differences between groups in the total retinal thickness measured by DRI-
Triton OCT (Figure 3), except for the TE (270.06 ± 22.36 µm vs. 269.38 ± 17.96 µm, control
vs. DM1 group, p = 0.701) and TI area (302.56 ± 23.97 µm vs. 311.46 ± 24.45 µm, control vs.
DM1 group, p = 0.100). DM1 patients had a higher retinal thickness than healthy controls
in practically all ETDRS areas, with the exception of the TE area.
Analyzing the GCL+ (Figure 3), there were no differences between both groups in
the SI area (91.38 ± 8.52 µm vs. 94.25 ± 13.34 µm, control vs. DM1 group, p = 0.073), TI
area (87.87 ± 8.83 µm vs. 89.94 ± 13.58 µm, control vs. DM1 group, p = 0.231) and the
central area (45.54 ± 14.03 µm vs. 50.52 ± 19.19 µm, control vs. DM1 group, p = 0.109) that
achieved significant differences in the total retinal thickness evaluation. We observed that
the TI area was maintained without differences between groups.
Evaluating the GCL++ (Figure 3), the areas that were different between groups de-
creased, showing differences only in the nasal and inferior areas (IE: 102.11 ± 10.62 µm
vs. 109.29 ± 18.72 µm, p = 0.028; NE: 106.92 ± 16.90 µm vs. 124.44 ± 15.76 µm, p < 0.001;
II: 117.45 ± 11.87 µm vs. 126.38 ± 25.44 µm, p = 0.019 and NI: 110.61 ± 9.56 µm vs.
118.98 ± 17.10 µm, p < 0.001 in the control vs. DM1 group). Furthermore, the thick-
est pattern continued in the DM1 group, except for the TE area (102.45 ± 16.76 µm vs.
97.75 ± 12.12 µm, control vs. DM1 group, p = 0.142).




Figure 3. Mean thickness of the total retina (from the ILM line to the BM line), GCL+ (from the 
RNFL line to the IPL line) and GCL++ (from the ILM line to the IPL line) in the 9 ETDRS areas ob-
tained by the DRI-Triton OCT for the control and the DM1 groups. Statistically significant differ-
ences between groups (p < 0.05) are marked with *. The measures are divided into 9 ETDRS areas. 
SE, superior external; TE, temporal external; IE, inferior externa; NE, nasal external; SI, superior 
internal; TI, temporal internal; II, inferior internal; NI, nasal internal; and C, central. Thickness 
values are expressed as μm. 
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area (45.54 ± 14.03 μm vs. 50.52 ± 19.19 μm, control vs. DM1 group, p = 0.109) that achieved 
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3.2. Comparative Analysis of Retinal Sensitivity 
Analyzing the data obtained by the MAIA (Figure 4), we observed a generalized de-
crease in sensitivity in the DM1 group compared to the control group. In addition, there 
were 9 areas with differences between both groups (p < 0.05): in the 5° radius, the areas 
were the II, TI and NI; in the 3° radius, the areas were the SI, II, TI and NI; and in the 1° 
radius, the areas were the SC and TC. The sensitivities of the different areas are shown in 
Figure 4. 
Figure 3. Mean thickness of the total retina (from the ILM line to the BM line), GCL+ (from the RNFL line to the IPL line)
and GCL++ (from the ILM line to the IPL line) in the 9 ETDRS areas obtained by the DRI-Triton OCT for the control and the
DM1 groups. Statistically significant differences between groups (p < 0.05) are marked with *. The measures are divided into
9 ETDRS areas. SE, superior external; TE, temporal external; IE, inferior externa; NE, nasal external; SI, superior internal; TI,
temporal internal; II, inferior internal; NI, nasal internal; and C, central. Thickness values are expressed as µm.
3.2. Comparative Analysis of Retinal Sensitivity
Analyzing the data obtained by the MAIA (Figure 4), we observed a generalized
decrease in sensitivity in the DM1 group compared to the control group. In addition, there
were 9 areas with differences between both groups (p < 0.05): in the 5◦ radius, the areas
were the II, TI and NI; in the 3◦ radius, the areas were the SI, II, TI and NI; and in the 1◦
radius, the areas were the SC and TC. The sensitivities of the different areas are shown
in Figure 4.
Diagnostics 2021, 11, x FOR PEER REVIEW 7 of 12 
 
 
Figure 4. Mean retinal sensitivity in dB measured by the MAIA microperimeter in the ETDRS ar-
eas corresponding to the 3-mm parafoveal ring divided into 2 subrings (mean of 3 points per area 
at 5° and 3°) and the 1-mm central ring divided into 2 subrings (mean of 3 points per area at 1° and 
a central point): 5SI, 5° superior internal; 5TI, 5° temporal internal; 5II, 5° inferior internal; 5NI, 5° 
nasal internal; 3SI, 3° superior internal; 3TI, 3° temporal internal; 3II, 3° inferior internal; 3NI, 3° 
nasal internal; 1SC, 1° superior central; 1TC, 1° temporal central; 1IC, 1° inferior central; 1NC, 1° 
nasal central; and 0C, 0° central. Statistically significant differences are at p < 0.05 and are marked 
with *. 
The rest of the parameters obtained by the MAIA are represented in Table 2. We only 
found differences in two of the analyzed parameters: the average threshold (28.16 ± 1.46 
dB vs. 26.44 ± 3.47 dB, control vs. DM1 group, p = 0.005) and the fixation losses (0.42 ± 
2.83% vs. 6.56 ± 12.99%, control vs. DM1 group, p = 0.013). 
Table 2. Mean and standard deviation (SD) of the rest of the parameters that the MAIA micrope-
rimeter offers for the control group and the DM1 group and a comparison between the values of 
both groups. The statistically significant values shown in bold and with an asterisk (p < 0.05). 
BCEA, Bivariate contour ellipse angle. The macular integrity and average threshold are measured 
in dB, the BCEA angle is measured in degrees, the area is measured in square degrees and fixation 
loses, P1, P2 are reported in %. 
 Control Group DM1 Group p 
 MEAN SD MEAN SD  
Macular integrity index 47.35 28.64 46.59 35.20 0.990 
Average threshold (dB) 28.16 1.46 26.44 3.46 0.005 * 
Fixation stability P1 (%) 86.47 18.22 87.44 14.67 0.982 
Fixation stability P2 (%) 95.70 7.43 96.64 4.91 0.492 
BCEA 63 area (°2) 6.47 9.87 4.73 7.21 0.833 
BCEA 63 angle (°) 9.36 62.36 2.01 60.84 0.477 
BCEA 95 area (°2) 6.42 9.85 4.70 7.31 0.817 
BCEA 95 angle (°) 9.36 62.36 1.52 61.19 0.468 
Fixation losses (%) 0.42 2.83 6.56 12.99 0.013 * 
3.3. Anatomo-Functional Correlation Study 
To correlate the structural and functional data obtained by DRI Triton SS-OCT and 
the MAIA, we used the Spearman test. 
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Figure 4. Mean retinal sensit vity in dB measured by the MAIA microperimeter in the ETDRS areas corresponding to the
3-mm parafoveal ring divid d into 2 subrings (mean of 3 points per rea at 5◦ and 3◦) and the 1-mm c ntral ring divid d
into 2 subrings (mean of 3 points per area at 1◦ and a central point): 5SI, 5◦ superior internal; 5TI, 5◦ temporal internal; 5II,
5◦ inferior internal; 5NI, 5◦ nasal internal; 3SI, 3◦ superior internal; 3TI, 3◦ temporal internal; 3II, 3◦ inferior internal; 3NI, 3◦
nasal internal; 1SC, 1◦ superior central; 1TC, 1◦ temporal central; 1IC, 1◦ inferior central; 1NC, 1◦ nasal central; and 0C, 0◦
central. Statistically significant differences are at p < 0.05 and are marked with *.
The rest of the parameters obtained by the MAIA are represented in Table 2. We only
found differences in two of the analyzed parameters: the average threshold (28.16 ± 1.46 dB
vs. 26.44 ± 3.47 dB, control vs. DM1 group, p = 0.005) and the fixation losses (0.42 ± 2.83%
vs. 6.56 ± 12.99%, control vs. DM1 group, p = 0.013).
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Table 2. Mean and standard deviation (SD) of the rest of the parameters that the MAIA microperime-
ter offers for the control group and the DM1 group and a comparison between the values of both
groups. The statistically significant values shown in bold and with an asterisk (p < 0.05). BCEA,
Bivariate contour ellipse angle. The macular integrity and average threshold are measured in dB, the
BCEA angle is measured in degrees, the area is measured in square degrees and fixation loses, P1, P2
are reported in %.
Control Group DM1 Group p
MEAN SD MEAN SD
Macular integrity index 47.35 28.64 46.59 35.20 0.990
Average threshold (dB) 28.16 1.46 26.44 3.46 0.005 *
Fixation stability P1 (%) 86.47 18.22 87.44 14.67 0.982
Fixation stability P2 (%) 95.70 7.43 96.64 4.91 0.492
BCEA 63 area (◦2) 6.47 9.87 4.73 7.21 0.833
BCEA 63 angle (◦) 9.36 62.36 2.01 60.84 0.477
BCEA 95 area (◦2) 6.42 9.85 4.70 7.31 0.817
BCEA 95 angle (◦) 9.36 62.36 1.52 61.19 0.468
Fixation losses (%) 0.42 2.83 6.56 12.99 0.013 *
3.3. Anatomo-Functional Correlation Study
To correlate the structural and functional data obtained by DRI Triton SS-OCT and the
MAIA, we used the Spearman test.
Regarding age, there was a significant negative correlation (p < 0.05) with retinal
sensitivity in all areas in DM1 patients and with VA in 2 areas of the 5◦ ring: 5SI (−0.356
with p = 0.011) and 5II (−0.301 with p < 0.034); and in 3 areas of the 3◦ ring: 3SI (−0.341
with p = 0.015), 3TI (−0.369 with p = 0.008) and 3II (−0.341 with p = 0.015). There was no
correlation between the sensitivity of the MAIA microperimeter and AL (Table 3).
Table 3. Spearman’s correlation between the retinal sensitivity measured by the MAIA microperimeter in the 9 ETDRS
areas and the different parameters of visual function and age for the DM1 group. Statistically significant difference between
groups (p < 0.05) are in bold. Correlation coefficient with p < 0.05 have one asterisk and with p < 0.01 have two asterisks.
Nine ETDRS areas: SE, superior external; TE, temporal external; IE, inferior external; NE, nasal external; SI, superior internal;
TI, temporal internal; II, inferior internal; NI, nasal internal; C-global, central; VA, visual acuity; SE, spherical equivalent;
AL, axial length; and IOP, intraocular pressure.
Retinal Sensitivity
5SI 5TI 5II 5NI 3SI 3TI 3II 3NI 0C
Age—correl coef. −0.413 ** −0.369 ** −0.493 ** −0.354 * −0.455 ** −0.398 ** −0.364 ** −0.410 ** −0.361 **
Sig. 0.003 0.008 <0.001 0.012 0.001 0.004 0.009 0.003 0.010
VA—correl coef. −0.356 * −0.256 −0.301 * −0.263 −0.341 * −0.369 ** −0.341 * −0.207 −0.195
Sig. 0.011 0.073 0.034 0.065 0.015 0.008 0.015 0.149 0.175
SE—correl coef. −0.336 * −0.262 −0.286 * −0.204 −0.412 ** −0.371 ** −0.290 * −0.232 −0.317 *
Sig. 0.017 0.066 0.044 0.155 0.003 0.008 0.041 0.105 0.025
AL—correl coef. 0.002 −0.053 −0.081 −0.121 −0.057 0.024 −0.048 −0.037 0.018
Sig. 0.989 0.715 0.574 0.404 0.693 0.869 0.739 0.801 0.903
IOP—correl coef. 0.314 * 0.239 0.205 0.193 0.267 0.300 * 0.146 0.293 * 0.276
Sig. 0.027 0.095 0.154 0.179 0.061 0.034 0.312 0.039 0.052
Table 4 shows the correlation between the thickness values in the central circle of the
ETDRS grid and the sensitivity values of the internal and central rings belonging to the
DM1 group. We did not find any correlation.
The correlations between the thicknesses of the 3 protocols in the four parafoveal inner
ETDRS areas (SI, TI, II and NI) with the measured thresholds of macular sensitivity in the 3
and 5◦ radii are also analyzed in Table 4. Only a mild negative correlation was observed in
the GCL++ protocol between retinal sensitivity in the 5NI area and thickness in the TI area
(−0.309 with p = 0.029).
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Table 4. Spearman’s correlation between the total retina (from the ILM to the BM line), GCL+
(from the RNFL to the IPL line) and GCL++ (from the ILM to the IPL line) thickness values in the
central circle obtained by DRI Triton SS-OCT and the retinal sensitivity values obtained by the MAIA
microperimeter in DM1 patients. Then, Spearman’s correlation between the parafoveal ETDRS areas
(SI, TI, II and NI) of the total retina, GCL+ and GCL++ thickness layers measured by DRI Triton
SS-OCT and the retinal sensitivity thresholds of the 3- and 5-degree radii measured by the MAIA
microperimeter in the DM1 group. Statistically significant differences are in bold (sig. p < 0.05). The 9
ETDRS areas are as follows: C global, central global ring; SE, superior external; TE, temporal external;
IE, inferior external; NE, nasal external; SI, superior internal; TI, temporal internal; II, inferior internal;
and NI, nasal internal; correl coef, correlation coefficient; sig, statistically significant.
ETDRS C (Retina) ETDRS C(GCL+)
ETDRS C
(GCL++)
0C global—Correl coef −0.180 −0.070 −0.134
Sig. 0.210 0.627 0.353







5SI—Correl coef 0.085 −0.037 −0.031 0.011
Sig. 0.559 0.798 0.833 0.939
5TI—Correl coef 0.138 −0.022 0.016 0.055
Sig. 0.340 0.882 0.912 0.705
5II—Correl coef 0.013 −0.109 −0.104 −0.066
Sig. 0.931 0.453 0.472 0.649
5NI—Correl coef 0.022 −0.111 −0.122 −0.087
Sig. 0.882 0.443 0.398 0.550
3SI—Correl coef 0.087 −0.069 −0.067 −0.012
Sig. 0.546 0.634 0.643 0.934
3TI—Correl coef 0.131 −0.054 −0.010 0.051
Sig. 0.363 0.711 0.947 0.724
3II—Correl coef 0.105 −0.037 −0.031 −0.005
Sig. 0.470 0.800 0.829 0.970
3NI—Correl coef 0.026 0.024 −0.089 −0.060
Sig. 0.855 0.870 0.539 0.680







5SI—Correl coef −0.002 0.051 −0.045 −0.082
Sig. 0.988 0.723 0.754 0.574
5TI—Correl coef 0.007 0.020 0.003 −0.048
Sig. 0.963 0.891 0.983 0.741
5II—Correl coef −0.087 −0.052 −0.129 −0.148
Sig. 0.549 0.721 0.371 0.305
5NI—Correl coef −0.122 −0.107 −0.184 −0.211
Sig. 0.399 0.459 0.201 0.140
3SI—Correl coef −0.046 −0.031 −0.113 −0.107
Sig. 0.752 0.832 0.434 0.460
3TI—Correl coef 0.050 0.044 −0.037 −0.018
Sig. 0.729 0.760 0.801 0.901
3II—Correl coef −0.038 −0.014 −0.087 −0.134
Sig. 0.794 0.922 0.550 0.352
3NI—Correl coef −0.032 −0.053 −0.109 −0.142
Sig. 0.828 0.713 0.451 0.327
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Table 4. Cont.
ETDRS C (Retina) ETDRS C(GCL+)
ETDRS C
(GCL++)
5SI—Correl coef 0.041 −0.104 −0.065 −0.132
Sig. 0.777 0.473 0.654 0.359
5TI—Correl coef 0.075 −0.102 −0.003 −0.055
Sig. 0.604 0.482 0.986 0.702
5II—Correl coef −0.033 −0.258 −0.139 −0.201
Sig. 0.820 0.070 0.337 0.162
5NI—Correl coef −0.062 −0.309 −0.208 −0.264
Sig. 0.670 0.029 0.148 0.064
3SI—Correl coef 0.026 −0.171 −0.105 −0.126
Sig. 0.855 0.234 0.467 0.383
3TI—Correl coef 0.119 −0.102 −0.017 −0.032
Sig. 0.412 0.480 0.907 0.823
3II—Correl coef 0.038 −0.163 −0.087 −0.156
Sig. 0.795 0.258 0.548 0.280
3NI—Correl coef 0.023 −0.232 −0.123 −0.184
Sig. 0.872 0.104 0.396 0.202
4. Discussion
In this study, we found higher macular thicknesses in the DM1 group. It could reflect
changes in the blood–retinal barrier, allowing fluid to enter the extravascular space, thereby
leading to retinal thickening in the macular area. Other possibilities that have been described
include modifications in Müller cells or an increase in the height of RPE cells [11,25].
The GCL+ and GCL++ (Figure 3) showed increased thickness at the macular level in
DM1 patients. The GC bodies were at the inner ring, and their axons were mainly located
at the perifoveal ring, justifying the foveal morphology. The loss of GCs due to apoptosis
and the neurodegeneration suffered by DM1 patients without DR suggests a functional
dysfunction manifested by the decreased VA with low contrast demonstrated in other
studies [4,6,14,26]. We correlated microperimetry values with the corresponding areas in
the ETDRS grid although there is no exact location of the respective fields. We did not
consider the displacement of the GCs from their respective fields due to the variability
between subjects [27].
The GCL decrease was also reflected in the control group related with aging; this has
already been demonstrated by other authors [26]. In the absence of differences between the
mean ages of both groups, our findings are accounted for by the disease.
We found a generalized decrease in sensitivity in all quadrants in the DM1 group
compared to the control group (Figure 4), including differences (p < 0.05) between groups
in 3 out of the 4 quadrants in the 5◦ ring, in all 4 quadrants of the 3◦ ring and in 2 out of the
4 quadrants of the 1◦ ring. Significant differences were seen in the 3 rings in the temporal
and inferior quadrants. A negative correlation was also seen between all sensitivity areas
and patient age. Other studies have described the same phenomenon: decreased sensitivity
was greater according to the earlier age at which they were found, and the severity of DR
progressed [28,29].
Regarding the patient fixation values (location and stability) obtained with the MAIA,
they were strongly associated with the patient’s visual function [28]. In Table 2, the fixation
stability is similar between groups, showing that the macular sensitivity and the VA were
not impaired. However, in DM1 patients, we observed a decreased macular integrity
without differences compared to the control group. However, there were differences
(p = 0.005) between groups in the average threshold, with lower values in the DM1 group
probably related to the slight decrease in VA in this group. The fixation was also affected,
with more fixation loss in DM1 patients (6.56%) than in the control group (0.42%) (p = 0.013).
In the anatomo-functional study, we found a negative correlation between VA and
retinal sensitivity (Table 3) since good VA depends on correct retinal neuron function [30].
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We found a decrease in GCs in the DM1 group; however, we cannot account for the loss
of VA.
We also showed a negative correlation in the central ring between the retinal thickness
and the retinal sensitivity (Table 4). These retinal changes are related to diminished
retinal sensitivity [29] but were not significant for any of the three retinal studied layers.
Furthermore, there was no decrease in retinal sensitivity in these patients.
Finally, only a significant negative correlation for the DM1 group was present (Table 4)
in the GCL++ between the retinal sensitivity in the 5NI area and thickness in the TI area
(−0.309 with p = 0.029). We did not find any other correlation between thickness and the
macular sensitivity in the DM1 group. In general, we observed that the thickness changes in
the different retinal layers caused a greater decrease in sensitivity in the temporal, inferior
and nasal quadrants of the parafoveal ring.
All these results helped us to clarify the doubt about which of the mechanisms is
the first one that triggers DR and whether it is a microvascular or neurodegenerative
damage mechanism. Sensitivity changes without anatomical findings on structural OCT
suggest that the second hypothesis is the most plausible option, as already postulated other
studies [2–12,15–18].
Microperimetry is an excellent functional test complementary to VA and the retinal
thickness measured with OCT. Thanks to the combination of these newly developed
technologies, we can detect any type of retinal damage prior to the onset of DR, and we are
able to treat affected patients before possibly irreversible complications have occurred.
5. Conclusions
In conclusion, aging and disease evolution in DM1 patients without DR signs generate
a decrease in retinal sensitivity. There was a direct relationship between retinal sensitivity
and macular thickness in the DM1 group.
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